Home » Healthcare » Neutralizing Antibody Market

Neutralizing Antibody Market By Type of Neutralizing Antibody (Monoclonal Antibodies (mAbs), Polyclonal Antibodies); By Application (Infectious Diseases, Cancer, Autoimmune Diseases); By End-User (Hospitals and Clinics, Pharmaceutical Companies, Research and Academic Institutions); By Disease Target (COVID-19, HIV, Hepatitis); By Technology and Production Process (Recombinant Antibodies, Hybridoma Technology, Phage Display Technology); By Region – Growth, Future Prospects & Competitive Analysis, 2022 – 2030

Summary
Table Of Content

Market Insights

The global demand for neutralizing antibodies was valued at USD 191254.5 million in 2022 and is expected to reach USD 378298.57 million in 2030, growing at a CAGR of 8.90% between 2023 and 2030.
Monoclonal antibodies (mAbs) are the leading segment by type of neutralizing antibody. On the other hand, polyclonal antibodies are expected to grow at a strong CAGR.
The leading application segment is cancer.
The CAGR for the hospitals and clinics is expected to be the highest during the projection period.
During the forecast time frame, the COVID-19 category will likely have the highest CAGR.
During the forecast period, recombinant antibodies are estimated to have the greatest CAGR.
The North American region dominates the neutralizing antibody market.
The market for neutralizing antibodies is expected to be ruled by Europe, which is expected to come in second.
Asia Pacific is anticipated to grow fastest in the market for neutralizing antibodies.
Concerns about world health, the rapid development of vaccines and treatments, and the creation of neutralizing antibody-based antiviral treatments are the main factors driving the market’s expansion.

Neutralizing antibody opportunities are created by biopharmaceutical investments, infrastructural improvements in healthcare, and international collaboration in research and development.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Executive Summary

Market Definition

Neutralizing antibodies are primarily used in creating, manufacturing, and distributing therapeutic antibodies intended to counteract the effects of particular infections. Neutralizing antibodies can be utilized as therapies or preventative measures in infectious diseases. Therefore, this is very pertinent.

Market Overview

The market for neutralizing antibody has been expanding steadily in recent years, and between 2023 and 2030, it is anticipated to rise at a CAGR of 8.90%. The market was estimated to be worth USD 191254.5 million in 2022 and is expected to be worth USD 378298.57 million in 2030.

The market for neutralizing antibodies is expanding due to the rise of infectious diseases, especially those that are new and extremely contagious. Targeting and neutralizing recently developing infections with neutralizing antibodies is possible. This is especially crucial in the early phases of an outbreak when vaccines and medicines may not yet be available. One of the most important tools for controlling epidemics is the quick development of neutralizing antibodies against a new infectious pathogen.

Effective remedies are frequently desperately needed during pandemics. Therapeutic medicines that neutralize antibodies can be created to lessen the severity of the disease and lower death rates. For example, the COVID-19 pandemic prompted a surge in research and development activities to produce neutralizing antibodies against the SARS-CoV-2 virus.

Prophylactic usage of neutralizing antibodies can also be used to stave off infections. In the context of newly developing infectious illnesses, preventive treatment with neutralizing antibodies may be beneficial to lower the risk of infection for people at high risk of exposure, such as healthcare workers or those in afflicted regions. Neutralizing antibodies can enhance vaccination techniques. Neutralizing antibodies can offer patients at risk or who have already contracted the disease an instant intervention in situations where vaccines may take some time to develop or are not always accessible.

Segmentation by Type of Neutralizing Antibody

Monoclonal antibodies (mAbs) are the market leader by type of neutralizing antibody. A wide range of illnesses, including cancer, autoimmune diseases, and infectious infections, are treated with monoclonal antibodies. The demand for mAbs is driven by the rising incidence of these illnesses.
The polyclonal antibodies category will exhibit a sizable CAGR during the projected period. Polyclonal antibodies have a wider variety of binding sites than monoclonal antibodies because they may recognize several epitopes on a target antigen. In some situations, this can be useful for detecting numerous targets at once.

Segmentation by Application

The main application category is cancer. When utilized for cancer treatment, monoclonal antibodies are designed to selectively target proteins on the surface of cancer cells or in the tissue around the tumour.
The infectious diseases category will likely register a significant CAGR during forecasting. In the immunological response to infectious illnesses, neutralizing antibodies is essential. These antibodies are specially made to identify and neutralize harmful substances like bacteria or viruses by hindering the pathogens’ capacity to infect host cells.
Other applications, such as autoimmune diseases, also contribute to the demand for neutralizing antibodies.

Segmentation by End-User

Over the forecast period, the category with the highest CAGR is expected to be hospitals and clinics. Hospitals offer various medical services, including surgery, diagnostic imaging, specialized therapies, emergency and critical care. Specialist medical care is provided by clinics that concentrate on particular medical specialities, including gastroenterology, dermatology, ophthalmology, and more.
Other end-users, such as pharmaceutical companies, research, and academic institutions, also contribute to the demand for neutralizing antibodies.

Segmentation by Disease Target

The COVID-19 category will likely have the highest CAGR during the projection period. Droplets of respiratory fluid created when an infected person coughs, talks, or sneezes are the primary means of COVID-19 transmission. It can also spread by coming into contact with contaminated surfaces and then touching the face.
Other disease targets, such as HIV and hepatitis, also contribute to the demand for neutralizing antibodies.

Segmentation by Technology and Production Process

The recombinant antibodies category will be expected to have the foremost CAGR during the prediction period. The field of antibody engineering has revolutionized due to recombinant antibody technology, which provides precise control over antibody characteristics and expands the applications of antibodies in research, medicine, and diagnostics. It remains an effective approach for creating novel medicinal and diagnostic compounds.
Other technologies and production processes, such as hybridoma and phage display technology, also contribute to the demand for neutralizing antibodies.

Segmentation by Region

In terms of neutralizing antibodies, North America held a leading position. The sector is growing due to the development of antibodies in North America to fight drug-resistant infections.
Europe is estimated to rank second in market size for neutralizing antibodies.
Asia Pacific will witness the most rapid growth in the neutralizing antibody market.
The remaining regions of the world, such as Africa, the Middle East, and Latin America, fulfil the remaining demand for neutralizing antibodies.

The growth of telehealth, the development of biosimilar neutralizing antibodies, and post-approval safety and efficacy monitoring are the factors supporting the global market expansion.

During forecasting, North America will probably rule the neutralizing antibody market. Neutralizing antibody sales have increased due to technological breakthroughs in antibody creation, bioprocessing, and manufacturing made possible by North America’s leadership in biopharmaceutical research. The region’s established infrastructure for research and development, which consists of biotechnology enterprises and academic institutions, encourages creativity in creating neutralizing antibodies.

The substantial amount of money spent on healthcare in North America encourages the development of novel therapeutics, such as neutralizing antibodies. It makes access to state-of-the-art medical care easier. The neutralizing antibody market is driven by research, development, and commercialization initiatives in North America by major pharmaceutical and biotechnology businesses.

According to the forecast, growth in the Asia Pacific region is expected to be the fastest. Neutralizing antibody innovation is being fostered by several Asia Pacific countries, such as China, India, and South Korea, emerging as biotechnology hubs. With its various patient demographics and regulatory support, the Asia Pacific area is emerging as a desirable location for clinical studies, particularly those involving neutralizing antibodies.

The rising availability and use of neutralizing antibodies are being facilitated by the arrival of multinational pharmaceutical corporations into the Asia Pacific market. A further significant factor propelling market growth in the Asia Pacific region is the increase in high-value investments in oncology and stem cell research and development.

Key Highlights of the Report

The global neutralizing antibody market is segmented by type of neutralizing antibody, application, end-user, disease target, technology and production process, and region. Regarding the type of neutralizing antibody, monoclonal antibodies (mAbs) are the market spearhead. Cancer is the top application segment. Over the course of the projected period, the hospitals and clinics are anticipated to increase at the fastest rate. It is projected that the recombinant antibodies would grow at the fastest rate during the forecast period. The market for neutralizing antibodies is expanding at a rapid pace in North America.

Standard biologics may be more reasonably priced when compared to biosimilars and biogenerics. Since neutralizing antibodies are often used to treat serious and chronic illnesses, patients, healthcare providers, and healthcare systems can all benefit from more accessible and reasonably priced solutions. Biosimilars and biogenerics may make greater patient access to essential therapies possible. This is extremely significant since neutralizing antibodies can be used to treat various diseases, such as cancer, autoimmune disorders, and infectious diseases. These are the factors that boost the growth of the neutralizing antibody market.

However, according to forecasts, North America will hold the largest market share for neutralizing antibodies globally. Growing COVID-19 treatment demand and ongoing attempts in North America to produce novel and more potent neutralizing antibodies drive the market’s expansion. Additionally, the Asia Pacific region is assumed to have the sharpest growth in the market. The expansion of the market in Asia Pacific is driven by the adoption of innovative methods in the manufacturing and delivery of neutralizing antibodies.

Which Key Factors Are Driving The Global Neutralizing Antibody Market?

The market for neutralizing antibodies is expanding due to several causes, including rising interest in regenerative medicine, greater public knowledge of health issues and available treatments, and integration with telemedicine platforms.

What Are The Key Challenges In The Global Market For Neutralizing Antibody?

Reimbursement issues, clinical evidence requirements, healthcare system capacity, and patient adherence hamper the market’s growth for neutralizing antibodies.

What Market Opportunities Exist For Neutralizing Antibody Globally?

The neutralizing antibody market has the potential to grow due to factors like investments in global health security, the emphasis on patient-centric approaches in healthcare, and the influence of ageing populations on healthcare demand.

Market Drivers

Several factors influence the market for neutralizing antibodies globally. The main factors influencing the market for neutralizing antibodies globally are as follows:

Rising Incidence of Chronic Diseases

A significant factor propelling the expansion of the neutralizing antibody market is the increased prevalence of chronic illnesses. Neutralizing antibodies are among the targeted medicines that can address the challenges associated with chronic diseases, which frequently include complex and long-term medical disorders. Neutralizing antibodies can specifically target elements linked to chronic illnesses, like certain proteins or cells that advance the disease. Comparing this focused strategy to broad-spectrum medicines enables more accurate and successful treatment techniques. Precision medicine is the idea that medical care should be customized to each patient’s unique characteristics, including their genetic composition and unique disease profile. By providing targeted medicines that target the particular biochemical pathways implicated in chronic diseases, neutralizing antibodies can contribute to precision medicine.

The increasing occurrence of chronic illnesses highlights the need for novel and focused therapeutic approaches, and neutralizing antibodies are positioned to play a significant role in this changing field. Neutralizing antibodies are becoming an essential part of the therapy toolkit for chronic illnesses, and this will probably lead to future expansion in the market due to ongoing research, technological improvements, and positive clinical outcomes.

Market Restraints

Several challenges could prevent the expansion of the global market for neutralizing antibodies. Among them are the following:

High Development Costs

High production costs constrain the neutralizing antibody market’s expansion. Comprehensive research is conducted in the early phases of drug development to determine viable targets and confirm the therapeutic strategy. Neutralizing antibodies are tested in vitro and on animals in preclinical research to determine their safety and effectiveness. These phases demand a significant outlay of funds. A crucial stage in developing neutralizing antibodies in clinical trials entails testing on human participants to assess dosage, safety, and effectiveness. These studies can be quite expensive to plan, carry out, and monitor, as well as comply with regulations. A costly and time-consuming procedure is required to meet regulatory requirements and receive permission from health authorities. Compliance with strict regulatory regulations is necessary for developers to neutralize antibodies, raising overall development expenses.

Opportunities

The global market for neutralizing antibodies presents significant potential opportunities. The following is an example of these:

Advancements in Antibody Engineering

Next-generation antibody formats, including bispecific and multispecific antibodies, as well as antibody-drug conjugates, have been made possible by antibody engineering. These formats provide prospects for more accurate and efficient neutralization of pathogens or disease targets by enabling innovative modes of action and enhanced targeting capabilities. Engineering techniques aim to improve the stability and pharmacokinetics of neutralizing antibodies. Antibody structural alterations, such as glycoengineering or Fc region engineering, can increase degradation resistance, half-life, and bioavailability. The specificity and affinity of antibody binding can be optimized through directed evolution techniques and rational design. Higher potency and selectivity antibodies may arise, enabling targeted neutralization of pathogens or targets linked to disease. The objective of antibody engineering techniques is to reduce the immunogenicity of therapeutic antibodies. The purpose of antibody sequence humanization, either totally or partially, is to lessen the possibility of an immunological reaction when patients are given neutralizing antibodies.

Competitive Landscape

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Players

The global market for neutralizing antibodies is very competitive, with many powerful players. Some of the leading market participants and their corresponding market shares are listed below:

Regeneron Pharmaceuticals, Inc.
Eli Lilly and Company
AstraZeneca PLC
GlaxoSmithKline plc
Sanofi SA
Roche Holding AG
Novartis AG
Merck & Co.Inc.
Pfizer Inc.
Johnson & Johnson
Takeda Pharmaceutical Company Limited
Moderna, Inc.
BioNTech SE
CSL Limited
Sinovac Biotech Ltd.
Others

To stay competitive, these businesses prioritize producing new products, growing their distribution network, and engaging in mergers and acquisitions.

The leading competitors in the global market for neutralizing antibodies are constantly looking for ways to get an advantage by releasing new items and advancements.

In June 2023, Cell Signaling Technology (CST) announced its collaboration with Lunaphore. This endeavour aimed to facilitate Lunaphore’s deployment of CST antibodies on the COMET platform, enhancing fully automated spatial biology.

In March 2023, Merck declared that it would produce and distribute BAVENCIO, or avelumab, an antibody that blocks the PD-L1. The business strengthened its oncology brand by regaining global rights to create this innovative treatment.

Summary of Key Findings

The industry for neutralizing antibodies has continued to grow due to the ongoing advancements in biotechnology.
The market is segmented by type of neutralizing antibody, application, end-user, disease target, technology and production process, and region.
The monoclonal antibodies (mAbs) category is experiencing an increase in market share.
The most ubiquitous application fragment is cancer.
Regarding CAGR, the hospitals and clinics are expected to grow fastest during the forecast period.
The category for recombinant antibodies will likely see the highest CAGR during the anticipated time frame.
North America is leading market development; the market is highly competitive with key players including Regeneron Pharmaceuticals, Inc., Eli Lilly and Company, AstraZeneca PLC, GlaxoSmithKline plc, Sanofi SA, Roche Holding AG, Novartis AG, Merck & Co.Inc., Pfizer Inc., Johnson & Johnson, Takeda Pharmaceutical Company Limited, Moderna, Inc., BioNTech SE, CSL Limited, Sinovac Biotech Ltd., and others.

Future Outlook

Optimistic viewpoint for the global neutralizing antibody market with noteworthy growth potential in the North American region.
The growth of innovation ecosystems in healthcare is the primary driver of the neutralizing antibody market.
Complex manufacturing processes could pose major challenges to the market’s growth within the anticipated time frame.
Foremost companies must concentrate on product innovation, expanding their market reach, and maintaining competitive pricing to stay ahead.

How CXOs Can Benefit from the Credence Research Neutralizing Antibody Market Report

The Credence Research Neutralizing Antibody Market Report provides CXOs with a comprehensive overview of the market, including:

Market size and growth forecast: The report provides detailed estimates of the global neutralizing antibody market size, segmented by type of neutralizing antibody, application, end-user, disease target, technology and production process, and region. It also includes forecasts for the market through 2032 based on key trends and drivers.
Market segmentation: The report segments the neutralizing antibody market by type of neutralizing antibody, application, end-user, disease target, technology and production process, and region. This segmentation provides CXOs with a granular understanding of the market and the opportunities in each segment.
Competitive landscape: The report profiles the key players in the neutralizing antibody market and provides insights into their strategies, product offerings, and financial performance. This information can help CXOs to identify and assess their competition.
Key trends and drivers: The report identifies and analyzes the key trends and drivers shaping the neutralizing antibody market. This information can help CXOs to make informed decisions about their investments and strategies.

CXOs can use the insights from the Credence Research Neutralizing Antibody Market Report to:

Identify growth opportunities: The report can help CXOs identify new growth opportunities in the neutralizing antibody market. For example, the report identifies the rising demand from hospitals and clinics for neutralizing antibodies as a key opportunity.
Make informed investment decisions: The report can help CXOs to make informed investment decisions about neutralizing antibody. For example, the report provides insights into the key factors to consider when evaluating neutralizing antibody providers and selecting neutralizing antibody solutions.
Develop competitive strategies: The report can help CXOs develop competitive strategies for their neutralizing antibody businesses. For example, the report identifies the key strategies that neutralizing antibody providers are using to differentiate themselves from their competitors.
Track market developments: The report can help CXOs to track market developments and stay ahead of the curve. For example, the report provides insights into the latest trends and innovations in the neutralizing antibody market.

Overall, the Credence Research Neutralizing Antibody Market Report is a valuable resource for CXOs who are looking to gain a deeper understanding of the market and identify growth opportunities.

Segmentation

By Type of Neutralizing Antibody
- Monoclonal Antibodies (mAbs)
- Polyclonal Antibodies
By Application
- Infectious Diseases
- Cancer
- Autoimmune Diseases
By End-User
- Hospitals and Clinics
- Pharmaceutical Companies
- Research and Academic Institutions
By Disease Target
- COVID-19
- HIV
- Hepatitis
By Technology and Production Process
- Recombinant Antibodies
- Hybridoma Technology
- Phage Display Technology
By Region
- North America
  - The U.S.
  - Canada
  - Mexico
- Europe
  - Germany
  - France
  - The U.K.
  - Italy
  - Spain
  - Rest of Europe
- Asia Pacific
  - China
  - Japan
  - India
  - South Korea
  - South-east Asia
  - Rest of Asia Pacific
- Latin America
  - Brazil
  - Argentina
  - Rest of Latin America
- Middle East & Africa
  - GCC Countries
  - South Africa
  - Rest of the Middle East and Africa

Table of Content

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Market Introduction
2. Executive Summary
2.1. Market Snapshot: Global Neutralizing Antibody Market
2.1.1. Global Neutralizing Antibody Market, By Type of Neutralizing Antibody
2.1.2. Global Neutralizing Antibody Market, By Application
2.1.3. Global Neutralizing Antibody Market, By End-User
2.1.4. Global Neutralizing Antibody Market, By Disease Target
2.1.5. Global Neutralizing Antibody Market, By Technology and Production Process
2.1.6. Global Neutralizing Antibody Market, By Region
2.2. Insights from Primary Respondents
3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Neutralizing Antibody Market Value, 2022-2030, (US$ Mn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Neutralizing Antibody Market Drivers
3.2.2. Neutralizing Antibody Market Restraints
3.2.3. Neutralizing Antibody Market Opportunities
3.2.4. Major Neutralizing Antibody Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Type of Neutralizing Antibody
3.5.2. Application
3.5.3. End-User
3.5.4. Disease Target
3.5.5. Technology and Production Process
3.5.6. Geography
4. Market Competitive Landscape Analysis
4.1. Company Market Share Analysis, 2022
4.1.1. Global Neutralizing Antibody Market: Company Market Share, Value 2022
4.1.2. Global Neutralizing Antibody Market: Top 6 Company Market Share, Value 2022
4.1.3. Global Neutralizing Antibody Market: Top 3 Company Market Share, Value 2022
4.2. Global Neutralizing Antibody Market: Company Revenue Share Analysis, 2022
4.3. Company Assessment Metrics, 2022
4.3.1. Stars
4.3.2. Emerging Leaders
4.3.3. Pervasive Players
4.3.4. Participants
4.4. Startups/ SMEs Assessment Metrics, 2022
4.4.1. Progressive Companies
4.4.2. Responsive Companies
4.4.3. Dynamic Companies
4.4.4. Starting Blocks
4.5. Strategic Development
4.5.1. Acquisition and Mergers
4.5.2. New Product Launch
4.5.3. Regional Expansion
4.5.4. Partnerships
4.6. Key Player Product Matrix
4.7. Potential for New Players in the Global Neutralizing Antibody Market
5. Premium Insights
5.1. STAR (Situation, Task, Action, Results) Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Bargaining Power of Buyers/Consumers
5.2.3. Bargaining Power of Suppliers
5.2.4. Threat of Substitute Types
5.2.5. Intensity of Competitive Rivalry
5.3. PESTEL Analysis
5.3.1. Political Factors
5.3.2. Economic Factors
5.3.3. Social Factors
5.3.4. Technological Factors
5.3.5. Environmental Factors
5.3.6. Legal Factors
5.4. Key Market Trends
5.4.1. Demand Side Trends
5.4.2. Supply Side Trends
5.5. Value Chain Analysis
5.6. Technology Analysis
5.6.1. Research and development in the global market
5.6.2. Patent Analysis
5.6.3. Emerging technologies and their potential disruption to the market
5.7. Consumer Behaviour Analysis
5.7.1. Consumer Preferences and Expectations
5.7.2. Factors Influencing Consumer Buying Decisions
5.7.2.1. North America
5.7.2.2. Europe
5.7.2.3. Asia Pacific
5.7.2.4. Latin America
5.7.2.5. Middle East and Africa
5.7.3. Consumer Pain Points
5.8. Analysis and Recommendations
5.9. Adjacent Market Analysis
6. Market Positioning of Key Players, 2022
6.1. Company market share of key players, 2022
6.2. Competitive Benchmarking
6.3. Market Positioning of Key Vendors
6.4. Geographical Presence Analysis
6.5. Major Strategies Adopted by Key Players
6.5.1. Key Strategies Analysis
6.5.2. Mergers and Acquisitions
6.5.3. Partnerships
6.5.4. Product Launch
6.5.5. Geographical Expansion
6.5.6. Others
7. Impact Analysis of COVID 19 and Russia – Ukraine War on Neutralizing Antibody Market
7.1. Ukraine-Russia War Impact
7.1.1. Uncertainty and Economic Instability
7.1.2. Supply chain disruptions
7.1.3. Regional market shifts
7.1.4. Shift in government priorities
7.2. COVID-19 Impact Analysis
7.2.1. Supply Chain Disruptions
7.2.2. Demand Fluctuations
7.2.3. Shift in Product Mix
7.2.4. Reduced Industrial Activity
7.2.5. Regional Impact Analysis
7.2.5.1. North America
7.2.5.2. Europe
7.2.5.3. Asia Pacific
7.2.5.4. Latin America
7.2.5.5. Middle East and Africa
8. Global Neutralizing Antibody Market, By Type of Neutralizing Antibody
8.1. Global Neutralizing Antibody Market Overview, by Type of Neutralizing Antibody
8.1.1. Global Neutralizing Antibody Market Revenue Share, By Type of Neutralizing Antibody, 2022 Vs 2030 (in %)
8.2. Monoclonal Antibodies (mAbs)
8.2.1. Global Neutralizing Antibody Market, By Monoclonal Antibodies (mAbs), By Region, 2022-2030 (US$ Mn)
8.2.2. Market Dynamics for Monoclonal Antibodies (mAbs)
8.2.2.1. Drivers
8.2.2.2. Restraints
8.2.2.3. Opportunities
8.2.2.4. Trends
8.3. Polyclonal Antibodies
8.3.1. Global Neutralizing Antibody Market, By Polyclonal Antibodies, By Region, 2022-2030 (US$ Mn)
8.3.2. Market Dynamics for Polyclonal Antibodies
8.3.2.1. Drivers
8.3.2.2. Restraints
8.3.2.3. Opportunities
8.3.2.4. Trends
9. Global Neutralizing Antibody Market, By Application
9.1. Global Neutralizing Antibody Market Overview, by Application
9.1.1. Global Neutralizing Antibody Market Revenue Share, By Application, 2022 Vs 2030 (in %)
9.2. Infectious Diseases
9.2.1. Global Neutralizing Antibody Market, By Infectious Diseases, By Region, 2022-2030 (US$ Mn)
9.2.2. Market Dynamics for Infectious Diseases
9.2.2.1. Drivers
9.2.2.2. Restraints
9.2.2.3. Opportunities
9.2.2.4. Trends
9.3. Cancer
9.3.1. Global Neutralizing Antibody Market, By Cancer, By Region, 2022-2030 (US$ Mn)
9.3.2. Market Dynamics for Cancer
9.3.2.1. Drivers
9.3.2.2. Restraints
9.3.2.3. Opportunities
9.3.2.4. Trends
9.4. Autoimmune Diseases
9.4.1. Global Neutralizing Antibody Market, By Autoimmune Diseases, By Region, 2022-2030 (US$ Mn)
9.4.2. Market Dynamics for Autoimmune Diseases
9.4.2.1. Drivers
9.4.2.2. Restraints
9.4.2.3. Opportunities
9.4.2.4. Trends
10. Global Neutralizing Antibody Market, By End-User
10.1. Global Neutralizing Antibody Market Overview, by End-User
10.1.1. Global Neutralizing Antibody Market Revenue Share, By End-User, 2022 Vs 2030 (in %)
10.2. Hospitals and Clinics
10.2.1. Global Neutralizing Antibody Market, By Hospitals and Clinics, By Region, 2022-2030 (US$ Mn)
10.2.2. Market Dynamics for Hospitals and Clinics
10.2.2.1. Drivers
10.2.2.2. Restraints
10.2.2.3. Opportunities
10.2.2.4. Trends
10.3. Pharmaceutical Companies
10.3.1. Global Neutralizing Antibody Market, By Pharmaceutical Companies, By Region, 2022-2030 (US$ Mn)
10.3.2. Market Dynamics for Pharmaceutical Companies
10.3.2.1. Drivers
10.3.2.2. Restraints
10.3.2.3. Opportunities
10.3.2.4. Trends
10.4. Research and Academic Institutions
10.4.1. Global Neutralizing Antibody Market, By Research and Academic Institutions, By Region, 2022-2030 (US$ Mn)
10.4.2. Market Dynamics for Research and Academic Institutions
10.4.2.1. Drivers
10.4.2.2. Restraints
10.4.2.3. Opportunities
10.4.2.4. Trends
11. Global Neutralizing Antibody Market, By Disease Target
11.1. Global Neutralizing Antibody Market Overview, by Disease Target
11.1.1. Global Neutralizing Antibody Market Revenue Share, By Disease Target, 2022 Vs 2030 (in %)
11.2. COVID-19
11.2.1. Global Neutralizing Antibody Market, By COVID-19, By Region, 2022-2030 (US$ Mn)
11.2.2. Market Dynamics for COVID-19
11.2.2.1. Drivers
11.2.2.2. Restraints
11.2.2.3. Opportunities
11.2.2.4. Trends
11.3. HIV
11.3.1. Global Neutralizing Antibody Market, By HIV, By Region, 2022-2030 (US$ Mn)
11.3.2. Market Dynamics for HIV
11.3.2.1. Drivers
11.3.2.2. Restraints
11.3.2.3. Opportunities
11.3.2.4. Trends
11.4. Hepatitis
11.4.1. Global Neutralizing Antibody Market, By Hepatitis, By Region, 2022-2030 (US$ Mn)
11.4.2. Market Dynamics for Hepatitis
11.4.2.1. Drivers
11.4.2.2. Restraints
11.4.2.3. Opportunities
11.4.2.4. Trends
12. Global Neutralizing Antibody Market, By Technology and Production Process
12.1. Global Neutralizing Antibody Market Overview, by Technology and Production Process
12.1.1. Global Neutralizing Antibody Market Revenue Share, By Technology and Production Process, 2022 Vs 2030 (in %)
12.2. Recombinant Antibodies
12.2.1. Global Neutralizing Antibody Market, By Recombinant Antibodies, By Region, 2022-2030 (US$ Mn)
12.2.2. Market Dynamics for Recombinant Antibodies
12.2.2.1. Drivers
12.2.2.2. Restraints
12.2.2.3. Opportunities
12.2.2.4. Trends
12.3. Hybridoma Technology
12.3.1. Global Neutralizing Antibody Market, By Hybridoma Technology, By Region, 2022-2030 (US$ Mn)
12.3.2. Market Dynamics for Hybridoma Technology
12.3.2.1. Drivers
12.3.2.2. Restraints
12.3.2.3. Opportunities
12.3.2.4. Trends
12.4. Phage Display Technology
12.4.1. Global Neutralizing Antibody Market, By Phage Display Technology, By Region, 2022-2030 (US$ Mn)
12.4.2. Market Dynamics for Phage Display Technology
12.4.2.1. Drivers
12.4.2.2. Restraints
12.4.2.3. Opportunities
12.4.2.4. Trends
13. Global Neutralizing Antibody Market, By Region
13.1. Global Neutralizing Antibody Market Overview, by Region
13.1.1. Global Neutralizing Antibody Market, By Region, 2022 vs 2030 (in%)
13.2. Type of Neutralizing Antibody
13.2.1. Global Neutralizing Antibody Market, By Type of Neutralizing Antibody, 2022-2030 (US$ Mn)
13.3. Application
13.3.1. Global Neutralizing Antibody Market, By Application, 2022-2030 (US$ Mn)
13.4. End-User
13.4.1. Global Neutralizing Antibody Market, By End-User, 2022-2030 (US$ Mn)
13.5. Disease Target
13.5.1. Global Neutralizing Antibody Market, By Disease Target, 2022-2030 (US$ Mn)
13.6. Technology and Production Process
13.6.1. Global Neutralizing Antibody Market, By Technology and Production Process, 2022-2030 (US$ Mn)
14. North America Neutralizing Antibody Market Analysis
14.1. Overview
14.1.1. Market Dynamics for North America
14.1.1.1. Drivers
14.1.1.2. Restraints
14.1.1.3. Opportunities
14.1.1.4. Trends
14.2. North America Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2017-2030(US$ Mn)
14.2.1. Overview
14.2.2. SRC Analysis
14.3. North America Neutralizing Antibody Market, by Application, 2017-2030(US$ Mn)
14.3.1. Overview
14.3.2. SRC Analysis
14.4. North America Neutralizing Antibody Market, by End-User, 2017-2030(US$ Mn)
14.4.1. Overview
14.4.2. SRC Analysis
14.5. North America Neutralizing Antibody Market, by Disease Target, 2017-2030(US$ Mn)
14.5.1. Overview
14.5.2. SRC Analysis
14.6. North America Neutralizing Antibody Market, by Technology and Production Process, 2017-2030(US$ Mn)
14.6.1. Overview
14.6.2. SRC Analysis
14.7. North America Neutralizing Antibody Market, by Country, 2022-2030 (US$ Mn)
14.7.1. North America Neutralizing Antibody Market, by Country, 2022 Vs 2030 (in%)
14.7.2. U.S.
14.7.3. Canada
14.7.4. Mexico
15. Europe Neutralizing Antibody Market Analysis
15.1. Overview
15.1.1. Market Dynamics for Europe
15.1.1.1. Drivers
15.1.1.2. Restraints
15.1.1.3. Opportunities
15.1.1.4. Trends
15.2. Europe Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2017-2030(US$ Mn)
15.2.1. Overview
15.2.2. SRC Analysis
15.3. Europe Neutralizing Antibody Market, by Application, 2017-2030(US$ Mn)
15.3.1. Overview
15.3.2. SRC Analysis
15.4. Europe Neutralizing Antibody Market, by End-User, 2017-2030(US$ Mn)
15.4.1. Overview
15.4.2. SRC Analysis
15.5. Europe Neutralizing Antibody Market, by Disease Target, 2017-2030(US$ Mn)
15.5.1. Overview
15.5.2. SRC Analysis
15.6. Europe Neutralizing Antibody Market, by Technology and Production Process, 2017-2030(US$ Mn)
15.6.1. Overview
15.6.2. SRC Analysis
15.7. Europe Neutralizing Antibody Market, by Country, 2022-2030 (US$ Mn)
15.7.1. Europe Neutralizing Antibody Market, by Country, 2022 Vs 2030 (in%)
15.7.2. UK
15.7.3. France
15.7.4. Germany
15.7.5. Italy
15.7.6. Spain
15.7.7. Benelux
15.7.8. Russia
15.7.9. Rest of Europe
16. Asia Pacific Neutralizing Antibody Market Analysis
16.1. Overview
16.1.1. Market Dynamics for Asia Pacific
16.1.1.1. Drivers
16.1.1.2. Restraints
16.1.1.3. Opportunities
16.1.1.4. Trends
16.2. Asia Pacific Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2017-2030(US$ Mn)
16.2.1. Overview
16.2.2. SRC Analysis
16.3. Asia Pacific Neutralizing Antibody Market, by Application, 2017-2030(US$ Mn)
16.3.1. Overview
16.3.2. SRC Analysis
16.4. Asia Pacific Neutralizing Antibody Market, by End-User, 2017-2030(US$ Mn)
16.4.1. Overview
16.4.2. SRC Analysis
16.5. Asia Pacific Neutralizing Antibody Market, by Disease Target, 2017-2030(US$ Mn)
16.5.1. Overview
16.5.2. SRC Analysis
16.6. Asia Pacific Neutralizing Antibody Market, by Technology and Production Process, 2017-2030(US$ Mn)
16.6.1. Overview
16.6.2. SRC Analysis
16.7. Asia Pacific Neutralizing Antibody Market, by Country, 2022-2030 (US$ Mn)
16.7.1. Asia Pacific Neutralizing Antibody Market, by Country, 2022 Vs 2030 (in%)
16.7.2. China
16.7.3. Japan
16.7.4. India
16.7.5. South Korea
16.7.6. South East Asia
16.7.7. Rest of Asia Pacific
17. Latin America Neutralizing Antibody Market Analysis
17.1. Overview
17.1.1. Market Dynamics for Latin America
17.1.1.1. Drivers
17.1.1.2. Restraints
17.1.1.3. Opportunities
17.1.1.4. Trends
17.2. Latin America Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2017-2030(US$ Mn)
17.2.1. Overview
17.2.2. SRC Analysis
17.3. Latin America Neutralizing Antibody Market, by Application, 2017-2030(US$ Mn)
17.3.1. Overview
17.3.2. SRC Analysis
17.4. Latin America Neutralizing Antibody Market, by End-User, 2017-2030(US$ Mn)
17.4.1. Overview
17.4.2. SRC Analysis
17.5. Latin America Neutralizing Antibody Market, by Disease Target, 2017-2030(US$ Mn)
17.5.1. Overview
17.5.2. SRC Analysis
17.6. Latin America Neutralizing Antibody Market, by Technology and Production Process, 2017-2030(US$ Mn)
17.6.1. Overview
17.6.2. SRC Analysis
17.7. Latin America Neutralizing Antibody Market, by Country, 2022-2030 (US$ Mn)
17.7.1. Latin America Neutralizing Antibody Market, by Country, 2022 Vs 2030 (in%)
17.7.2. Brazil
17.7.3. Argentina
17.7.4. Rest of Latin America
18. Middle East Neutralizing Antibody Market Analysis
18.1. Overview
18.1.1. Market Dynamics for Middle East
18.1.1.1. Drivers
18.1.1.2. Restraints
18.1.1.3. Opportunities
18.1.1.4. Trends
18.2. Middle East Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2017-2030(US$ Mn)
18.2.1. Overview
18.2.2. SRC Analysis
18.3. Middle East Neutralizing Antibody Market, by Application, 2017-2030(US$ Mn)
18.3.1. Overview
18.3.2. SRC Analysis
18.4. Middle East Neutralizing Antibody Market, by End-User, 2017-2030(US$ Mn)
18.4.1. Overview
18.4.2. SRC Analysis
18.5. Middle East Neutralizing Antibody Market, by Disease Target, 2017-2030(US$ Mn)
18.5.1. Overview
18.5.2. SRC Analysis
18.6. Middle East Neutralizing Antibody Market, by Technology and Production Process, 2017-2030(US$ Mn)
18.6.1. Overview
18.6.2. SRC Analysis
18.7. Middle East Neutralizing Antibody Market, by Country, 2022-2030 (US$ Mn)
18.7.1. Middle East Neutralizing Antibody Market, by Country, 2022 Vs 2030 (in%)
18.7.2. UAE
18.7.3. Saudi Arabia
18.7.4. Rest of Middle East
19. Africa Neutralizing Antibody Market Analysis
19.1. Overview
19.1.1. Market Dynamics for Africa
19.1.1.1. Drivers
19.1.1.2. Restraints
19.1.1.3. Opportunities
19.1.1.4. Trends
19.2. Africa Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2017-2030(US$ Mn)
19.2.1. Overview
19.2.2. SRC Analysis
19.3. Africa Neutralizing Antibody Market, by Application, 2017-2030(US$ Mn)
19.3.1. Overview
19.3.2. SRC Analysis
19.4. Africa Neutralizing Antibody Market, by End-User, 2017-2030(US$ Mn)
19.4.1. Overview
19.4.2. SRC Analysis
19.5. Africa Neutralizing Antibody Market, by Disease Target, 2017-2030(US$ Mn)
19.5.1. Overview
19.5.2. SRC Analysis
19.6. Africa Neutralizing Antibody Market, by Technology and Production Process, 2017-2030(US$ Mn)
19.6.1. Overview
19.6.2. SRC Analysis
19.7. Africa Neutralizing Antibody Market, by Country, 2022-2030 (US$ Mn)
19.7.1. Africa Neutralizing Antibody Market, by Country, 2022 Vs 2030 (in%)
19.7.2. South Africa
19.7.3. Egypt
19.7.4. Rest of Africa
20. Company profiles
20.1. Regeneron Pharmaceuticals, Inc.
20.1.1. Company Overview
20.1.2. Products/Services Portfolio
20.1.3. Geographical Presence
20.1.4. SWOT Analysis
20.1.5. Financial Summary
20.1.5.1. Market Revenue and Net Profit (2019-2022)
20.1.5.2. Business Segment Revenue Analysis
20.1.5.3. Geographical Revenue Analysis
20.2. Eli Lilly and Company
20.3. AstraZeneca PLC
20.4. GlaxoSmithKline plc
20.5. Sanofi SA
20.6. Roche Holding AG
20.7. Novartis AG
20.8. Merck & Co.Inc.
20.9. Pfizer Inc.
20.10. Johnson & Johnson
20.11. Takeda Pharmaceutical Company Limited
20.12. Moderna, Inc.
20.13. BioNTech SE
20.14. CSL Limited
20.15. Sinovac Biotech Ltd.
20.16. Others
21. Research Methodology
21.1. Research Methodology
21.2. Phase I – Secondary Research
21.3. Phase II – Data Modelling
21.3.1. Company Share Analysis Model
21.3.2. Revenue Based Modelling
21.4. Phase III – Primary Research
21.5. Research Limitations
21.5.1. Assumptions

List of Figures
FIG. 1 Global Neutralizing Antibody Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Neutralizing Antibody Market Segmentation
FIG. 4 Global Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2022 (US$ Mn)
FIG. 5 Global Neutralizing Antibody Market, by Application, 2022 (US$ Mn)
FIG. 6 Global Neutralizing Antibody Market, by End-User, 2022 (US$ Mn)
FIG. 7 Global Neutralizing Antibody Market, by Disease Target, 2022 (US$ Mn)
FIG. 8 Global Neutralizing Antibody Market, by Technology and Production Process, 2022 (US$ Mn)
FIG. 9 Global Neutralizing Antibody Market, by Geography, 2022 (US$ Mn)
FIG. 10 Attractive Investment Proposition, by Type of Neutralizing Antibody, 2022
FIG. 11 Attractive Investment Proposition, by Application, 2022
FIG. 12 Attractive Investment Proposition, by End-User, 2022
FIG. 13 Attractive Investment Proposition, by Disease Target, 2022
FIG. 14 Attractive Investment Proposition, by Technology and Production Process, 2022
FIG. 15 Attractive Investment Proposition, by Geography, 2022
FIG. 16 Global Market Share Analysis of Key Neutralizing Antibody Market Manufacturers, 2022
FIG. 17 Global Market Positioning of Key Neutralizing Antibody Market Manufacturers, 2022
FIG. 18 Global Neutralizing Antibody Market Value Contribution, By Type of Neutralizing Antibody, 2022 & 2030 (Value %)
FIG. 19 Global Neutralizing Antibody Market, by Monoclonal Antibodies (mAbs), Value, 2022-2030 (US$ Mn)
FIG. 20 Global Neutralizing Antibody Market, by Polyclonal Antibodies, Value, 2022-2030 (US$ Mn)
FIG. 21 Global Neutralizing Antibody Market Value Contribution, By Application, 2022 & 2030 (Value %)
FIG. 22 Global Neutralizing Antibody Market, by Infectious Diseases, Value, 2022-2030 (US$ Mn)
FIG. 23 Global Neutralizing Antibody Market, by Cancer, Value, 2022-2030 (US$ Mn)
FIG. 24 Global Neutralizing Antibody Market, by Autoimmune Diseases, Value, 2022-2030 (US$ Mn)
FIG. 25 Global Neutralizing Antibody Market Value Contribution, By End-User, 2022 & 2030 (Value %)
FIG. 26 Global Neutralizing Antibody Market, by Hospitals and Clinics, Value, 2022-2030 (US$ Mn)
FIG. 27 Global Neutralizing Antibody Market, by Pharmaceutical Companies, Value, 2022-2030 (US$ Mn)
FIG. 28 Global Neutralizing Antibody Market, by Research and Academic Institutions, Value, 2022-2030 (US$ Mn)
FIG. 29 Global Neutralizing Antibody Market Value Contribution, By Disease Target, 2022 & 2030 (Value %)
FIG. 30 Global Neutralizing Antibody Market, by COVID-19, Value, 2022-2030 (US$ Mn)
FIG. 31 Global Neutralizing Antibody Market, by HIV, Value, 2022-2030 (US$ Mn)
FIG. 32 Global Neutralizing Antibody Market, by Hepatitis, Value, 2022-2030 (US$ Mn)
FIG. 33 Global Neutralizing Antibody Market Value Contribution, By Technology and Production Process, 2022 & 2030 (Value %)
FIG. 34 Global Neutralizing Antibody Market, by Recombinant Antibodies, Value, 2022-2030 (US$ Mn)
FIG. 35 Global Neutralizing Antibody Market, by Hybridoma Technology, Value, 2022-2030 (US$ Mn)
FIG. 36 Global Neutralizing Antibody Market, by Phage Display Technology, Value, 2022-2030 (US$ Mn)
FIG. 37 North America Neutralizing Antibody Market, 2022-2030 (US$ Mn)
FIG. 38 U.S. Neutralizing Antibody Market, 2022-2030 (US$ Mn)
FIG. 39 Canada Neutralizing Antibody Market, 2022-2030 (US$ Mn)
FIG. 40 Mexico Neutralizing Antibody Market, 2022-2030 (US$ Mn)
FIG. 41 Europe Neutralizing Antibody Market, 2022-2030 (US$ Mn)
FIG. 42 Germany Neutralizing Antibody Market, 2022-2030 (US$ Mn)
FIG. 43 France Neutralizing Antibody Market, 2022-2030 (US$ Mn)
FIG. 44 U.K. Neutralizing Antibody Market, 2022-2030 (US$ Mn)
FIG. 45 Italy Neutralizing Antibody Market, 2022-2030 (US$ Mn)
FIG. 46 Spain Neutralizing Antibody Market, 2022-2030 (US$ Mn)
FIG. 47 Benelux Neutralizing Antibody Market, 2022-2030 (US$ Mn)
FIG. 48 Russia Neutralizing Antibody Market, 2022-2030 (US$ Mn)
FIG. 49 Rest of Europe Neutralizing Antibody Market, 2022-2030 (US$ Mn)
FIG. 50 Asia Pacific Neutralizing Antibody Market, 2022-2030 (US$ Mn)
FIG. 51 China Neutralizing Antibody Market, 2022-2030 (US$ Mn)
FIG. 52 Japan Neutralizing Antibody Market, 2022-2030 (US$ Mn)
FIG. 53 India Neutralizing Antibody Market, 2022-2030 (US$ Mn)
FIG. 54 South Korea Neutralizing Antibody Market, 2022-2030 (US$ Mn)
FIG. 55 South-East Asia Neutralizing Antibody Market, 2022-2030 (US$ Mn)
FIG. 56 Rest of Asia Pacific Neutralizing Antibody Market, 2022-2030 (US$ Mn)
FIG. 57 Latin America Neutralizing Antibody Market, 2022-2030 (US$ Mn)
FIG. 58 Brazil Neutralizing Antibody Market, 2022-2030 (US$ Mn)
FIG. 59 Argentina Neutralizing Antibody Market, 2022-2030 (US$ Mn)
FIG. 60 Rest of Latin America Neutralizing Antibody Market, 2022-2030 (US$ Mn)
FIG. 61 Middle East Neutralizing Antibody Market, 2022-2030 (US$ Mn)
FIG. 62 UAE Neutralizing Antibody Market, 2022-2030 (US$ Mn)
FIG. 63 Saudi Arabia Neutralizing Antibody Market, 2022-2030 (US$ Mn)
FIG. 64 Rest of Middle East Neutralizing Antibody Market, 2022-2030 (US$ Mn)
FIG. 65 Africa Neutralizing Antibody Market, 2022-2030 (US$ Mn)
FIG. 66 South Africa Neutralizing Antibody Market, 2022-2030 (US$ Mn)
FIG. 67 Egypt Neutralizing Antibody Market, 2022-2030 (US$ Mn)
FIG. 68 Rest of Africa Neutralizing Antibody Market, 2022-2030 (US$ Mn)

List of Tables
TABLE 1 Market Snapshot: Global Neutralizing Antibody Market
TABLE 2 Global Neutralizing Antibody Market: Market Drivers Impact Analysis
TABLE 3 Global Neutralizing Antibody Market: Market Restraints Impact Analysis
TABLE 4 Global Neutralizing Antibody Market, by Competitive Benchmarking, 2022
TABLE 5 Global Neutralizing Antibody Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Neutralizing Antibody Market, by Key Strategies Analysis, 2022
TABLE 7 Global Neutralizing Antibody Market, by Monoclonal Antibodies (mAbs), By Region, 2017-2022 (US$ Mn)
TABLE 8 Global Neutralizing Antibody Market, by Monoclonal Antibodies (mAbs), By Region, 2023-2030 (US$ Mn)
TABLE 9 Global Neutralizing Antibody Market, by Polyclonal Antibodies, By Region, 2017-2022 (US$ Mn)
TABLE 10 Global Neutralizing Antibody Market, by Polyclonal Antibodies, By Region, 2023-2030 (US$ Mn)
TABLE 11 Global Neutralizing Antibody Market, by Infectious Diseases, By Region, 2017-2022 (US$ Mn)
TABLE 12 Global Neutralizing Antibody Market, by Infectious Diseases, By Region, 2023-2030 (US$ Mn)
TABLE 13 Global Neutralizing Antibody Market, by Cancer, By Region, 2017-2022 (US$ Mn)
TABLE 14 Global Neutralizing Antibody Market, by Cancer, By Region, 2023-2030 (US$ Mn)
TABLE 15 Global Neutralizing Antibody Market, by Autoimmune Diseases, By Region, 2017-2022 (US$ Mn)
TABLE 16 Global Neutralizing Antibody Market, by Autoimmune Diseases, By Region, 2023-2030 (US$ Mn)
TABLE 17 Global Neutralizing Antibody Market, by Hospitals and Clinics, By Region, 2017-2022 (US$ Mn)
TABLE 18 Global Neutralizing Antibody Market, by Hospitals and Clinics, By Region, 2023-2030 (US$ Mn)
TABLE 19 Global Neutralizing Antibody Market, by Pharmaceutical Companies, By Region, 2017-2022 (US$ Mn)
TABLE 20 Global Neutralizing Antibody Market, by Pharmaceutical Companies, By Region, 2023-2030 (US$ Mn)
TABLE 21 Global Neutralizing Antibody Market, by Research and Academic Institutions, By Region, 2017-2022 (US$ Mn)
TABLE 22 Global Neutralizing Antibody Market, by Research and Academic Institutions, By Region, 2023-2030 (US$ Mn)
TABLE 23 Global Neutralizing Antibody Market, by COVID-19, By Region, 2017-2022 (US$ Mn)
TABLE 24 Global Neutralizing Antibody Market, by COVID-19, By Region, 2023-2030 (US$ Mn)
TABLE 25 Global Neutralizing Antibody Market, by HIV, By Region, 2017-2022 (US$ Mn)
TABLE 26 Global Neutralizing Antibody Market, by HIV, By Region, 2023-2030 (US$ Mn)
TABLE 27 Global Neutralizing Antibody Market, by Hepatitis, By Region, 2017-2022 (US$ Mn)
TABLE 28 Global Neutralizing Antibody Market, by Hepatitis, By Region, 2023-2030 (US$ Mn)
TABLE 29 Global Neutralizing Antibody Market, by Recombinant Antibodies, By Region, 2017-2022 (US$ Mn)
TABLE 30 Global Neutralizing Antibody Market, by Recombinant Antibodies, By Region, 2023-2030 (US$ Mn)
TABLE 31 Global Neutralizing Antibody Market, by Hybridoma Technology, By Region, 2017-2022 (US$ Mn)
TABLE 32 Global Neutralizing Antibody Market, by Hybridoma Technology, By Region, 2023-2030 (US$ Mn)
TABLE 33 Global Neutralizing Antibody Market, by Phage Display Technology, By Region, 2017-2022 (US$ Mn)
TABLE 34 Global Neutralizing Antibody Market, by Phage Display Technology, By Region, 2023-2030 (US$ Mn)
TABLE 35 Global Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2017-2022 (US$ Mn)
TABLE 36 Global Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2023-2030 (US$ Mn)
TABLE 37 Global Neutralizing Antibody Market, by Application, 2017-2022 (US$ Mn)
TABLE 38 Global Neutralizing Antibody Market, by Application, 2023-2030 (US$ Mn)
TABLE 39 Global Neutralizing Antibody Market, by End-User, 2017-2022 (US$ Mn)
TABLE 40 Global Neutralizing Antibody Market, by End-User, 2023-2030 (US$ Mn)
TABLE 41 Global Neutralizing Antibody Market, by Disease Target, 2017-2022 (US$ Mn)
TABLE 42 Global Neutralizing Antibody Market, by Disease Target, 2023-2030 (US$ Mn)
TABLE 43 Global Neutralizing Antibody Market, by Technology and Production Process, 2017-2022 (US$ Mn)
TABLE 44 Global Neutralizing Antibody Market, by Technology and Production Process, 2023-2030 (US$ Mn)
TABLE 45 Global Neutralizing Antibody Market, by Region, 2017-2022 (US$ Mn)
TABLE 46 Global Neutralizing Antibody Market, by Region, 2023-2030 (US$ Mn)
TABLE 47 North America Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2017-2022 (US$ Mn)
TABLE 48 North America Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2023-2030 (US$ Mn)
TABLE 49 North America Neutralizing Antibody Market, by Application, 2017-2022 (US$ Mn)
TABLE 50 North America Neutralizing Antibody Market, by Application, 2023-2030 (US$ Mn)
TABLE 51 North America Neutralizing Antibody Market, by End-User, 2017-2022 (US$ Mn)
TABLE 52 North America Neutralizing Antibody Market, by End-User, 2023-2030 (US$ Mn)
TABLE 53 North America Neutralizing Antibody Market, by Disease Target, 2017-2022 (US$ Mn)
TABLE 54 North America Neutralizing Antibody Market, by Disease Target, 2023-2030 (US$ Mn)
TABLE 55 North America Neutralizing Antibody Market, by Technology and Production Process, 2017-2022 (US$ Mn)
TABLE 56 North America Neutralizing Antibody Market, by Technology and Production Process, 2023-2030 (US$ Mn)
TABLE 57 North America Neutralizing Antibody Market, by Country, 2017-2022 (US$ Mn)
TABLE 58 North America Neutralizing Antibody Market, by Country, 2023-2030 (US$ Mn)
TABLE 59 United States Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2017-2022 (US$ Mn)
TABLE 60 United States Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2023-2030 (US$ Mn)
TABLE 61 United States Neutralizing Antibody Market, by Application, 2017-2022 (US$ Mn)
TABLE 62 United States Neutralizing Antibody Market, by Application, 2023-2030 (US$ Mn)
TABLE 63 United States Neutralizing Antibody Market, by End-User, 2017-2022 (US$ Mn)
TABLE 64 United States Neutralizing Antibody Market, by End-User, 2023-2030 (US$ Mn)
TABLE 65 United States Neutralizing Antibody Market, by Disease Target, 2017-2022 (US$ Mn)
TABLE 66 United States Neutralizing Antibody Market, by Disease Target, 2023-2030 (US$ Mn)
TABLE 67 United States Neutralizing Antibody Market, by Technology and Production Process, 2017-2022 (US$ Mn)
TABLE 68 United States Neutralizing Antibody Market, by Technology and Production Process, 2023-2030 (US$ Mn)
TABLE 69 Canada Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2017-2022 (US$ Mn)
TABLE 70 Canada Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2023-2030 (US$ Mn)
TABLE 71 Canada Neutralizing Antibody Market, by Application, 2017-2022 (US$ Mn)
TABLE 72 Canada Neutralizing Antibody Market, by Application, 2023-2030 (US$ Mn)
TABLE 73 Canada Neutralizing Antibody Market, by End-User, 2017-2022 (US$ Mn)
TABLE 74 Canada Neutralizing Antibody Market, by End-User, 2023-2030 (US$ Mn)
TABLE 75 Canada Neutralizing Antibody Market, by Disease Target, 2017-2022 (US$ Mn)
TABLE 76 Canada Neutralizing Antibody Market, by Disease Target, 2023-2030 (US$ Mn)
TABLE 77 Canada Neutralizing Antibody Market, by Technology and Production Process, 2017-2022 (US$ Mn)
TABLE 78 Canada Neutralizing Antibody Market, by Technology and Production Process, 2023-2030 (US$ Mn)
TABLE 79 Mexico Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2017-2022 (US$ Mn)
TABLE 80 Mexico Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2023-2030 (US$ Mn)
TABLE 81 Mexico Neutralizing Antibody Market, by Application, 2017-2022 (US$ Mn)
TABLE 82 Mexico Neutralizing Antibody Market, by Application, 2023-2030 (US$ Mn)
TABLE 83 Mexico Neutralizing Antibody Market, by End-User, 2017-2022 (US$ Mn)
TABLE 84 Mexico Neutralizing Antibody Market, by End-User, 2023-2030 (US$ Mn)
TABLE 85 Mexico Neutralizing Antibody Market, by Disease Target, 2017-2022 (US$ Mn)
TABLE 86 Mexico Neutralizing Antibody Market, by Disease Target, 2023-2030 (US$ Mn)
TABLE 87 Mexico Neutralizing Antibody Market, by Technology and Production Process, 2017-2022 (US$ Mn)
TABLE 88 Mexico Neutralizing Antibody Market, by Technology and Production Process, 2023-2030 (US$ Mn)
TABLE 89 Europe Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2017-2022 (US$ Mn)
TABLE 90 Europe Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2023-2030 (US$ Mn)
TABLE 91 Europe Neutralizing Antibody Market, by Application, 2017-2022 (US$ Mn)
TABLE 92 Europe Neutralizing Antibody Market, by Application, 2023-2030 (US$ Mn)
TABLE 93 Europe Neutralizing Antibody Market, by End-User, 2017-2022 (US$ Mn)
TABLE 94 Europe Neutralizing Antibody Market, by End-User, 2023-2030 (US$ Mn)
TABLE 95 Europe Neutralizing Antibody Market, by Disease Target, 2017-2022 (US$ Mn)
TABLE 96 Europe Neutralizing Antibody Market, by Disease Target, 2023-2030 (US$ Mn)
TABLE 97 Europe Neutralizing Antibody Market, by Technology and Production Process, 2017-2022 (US$ Mn)
TABLE 98 Europe Neutralizing Antibody Market, by Technology and Production Process, 2023-2030 (US$ Mn)
TABLE 99 Europe Neutralizing Antibody Market, by Country, 2017-2022 (US$ Mn)
TABLE 100 Europe Neutralizing Antibody Market, by Country, 2023-2030 (US$ Mn)
TABLE 101 Germany Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2017-2022 (US$ Mn)
TABLE 102 Germany Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2023-2030 (US$ Mn)
TABLE 103 Germany Neutralizing Antibody Market, by Application, 2017-2022 (US$ Mn)
TABLE 104 Germany Neutralizing Antibody Market, by Application, 2023-2030 (US$ Mn)
TABLE 105 Germany Neutralizing Antibody Market, by End-User, 2017-2022 (US$ Mn)
TABLE 106 Germany Neutralizing Antibody Market, by End-User, 2023-2030 (US$ Mn)
TABLE 107 Germany Neutralizing Antibody Market, by Disease Target, 2017-2022 (US$ Mn)
TABLE 108 Germany Neutralizing Antibody Market, by Disease Target, 2023-2030 (US$ Mn)
TABLE 109 Germany Neutralizing Antibody Market, by Technology and Production Process, 2017-2022 (US$ Mn)
TABLE 110 Germany Neutralizing Antibody Market, by Technology and Production Process, 2023-2030 (US$ Mn)
TABLE 111 France Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2017-2022 (US$ Mn)
TABLE 112 France Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2023-2030 (US$ Mn)
TABLE 113 France Neutralizing Antibody Market, by Application, 2017-2022 (US$ Mn)
TABLE 114 France Neutralizing Antibody Market, by Application, 2023-2030 (US$ Mn)
TABLE 115 France Neutralizing Antibody Market, by End-User, 2017-2022 (US$ Mn)
TABLE 116 France Neutralizing Antibody Market, by End-User, 2023-2030 (US$ Mn)
TABLE 117 France Neutralizing Antibody Market, by Disease Target, 2017-2022 (US$ Mn)
TABLE 118 France Neutralizing Antibody Market, by Disease Target, 2023-2030 (US$ Mn)
TABLE 119 France Neutralizing Antibody Market, by Technology and Production Process, 2017-2022 (US$ Mn)
TABLE 120 France Neutralizing Antibody Market, by Technology and Production Process, 2023-2030 (US$ Mn)
TABLE 121 United Kingdom Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2017-2022 (US$ Mn)
TABLE 122 United Kingdom Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2023-2030 (US$ Mn)
TABLE 123 United Kingdom Neutralizing Antibody Market, by Application, 2017-2022 (US$ Mn)
TABLE 124 United Kingdom Neutralizing Antibody Market, by Application, 2023-2030 (US$ Mn)
TABLE 125 United Kingdom Neutralizing Antibody Market, by End-User, 2017-2022 (US$ Mn)
TABLE 126 United Kingdom Neutralizing Antibody Market, by End-User, 2023-2030 (US$ Mn)
TABLE 127 United Kingdom Neutralizing Antibody Market, by Disease Target, 2017-2022 (US$ Mn)
TABLE 128 United Kingdom Neutralizing Antibody Market, by Disease Target, 2023-2030 (US$ Mn)
TABLE 129 United Kingdom Neutralizing Antibody Market, by Technology and Production Process, 2017-2022 (US$ Mn)
TABLE 130 United Kingdom Neutralizing Antibody Market, by Technology and Production Process, 2023-2030 (US$ Mn)
TABLE 131 Italy Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2017-2022 (US$ Mn)
TABLE 132 Italy Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2023-2030 (US$ Mn)
TABLE 133 Italy Neutralizing Antibody Market, by Application, 2017-2022 (US$ Mn)
TABLE 134 Italy Neutralizing Antibody Market, by Application, 2023-2030 (US$ Mn)
TABLE 135 Italy Neutralizing Antibody Market, by End-User, 2017-2022 (US$ Mn)
TABLE 136 Italy Neutralizing Antibody Market, by End-User, 2023-2030 (US$ Mn)
TABLE 137 Italy Neutralizing Antibody Market, by Disease Target, 2017-2022 (US$ Mn)
TABLE 138 Italy Neutralizing Antibody Market, by Disease Target, 2023-2030 (US$ Mn)
TABLE 139 Italy Neutralizing Antibody Market, by Technology and Production Process, 2017-2022 (US$ Mn)
TABLE 140 Italy Neutralizing Antibody Market, by Technology and Production Process, 2023-2030 (US$ Mn)
TABLE 141 Spain Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2017-2022 (US$ Mn)
TABLE 142 Spain Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2023-2030 (US$ Mn)
TABLE 143 Spain Neutralizing Antibody Market, by Application, 2017-2022 (US$ Mn)
TABLE 144 Spain Neutralizing Antibody Market, by Application, 2023-2030 (US$ Mn)
TABLE 145 Spain Neutralizing Antibody Market, by End-User, 2017-2022 (US$ Mn)
TABLE 146 Spain Neutralizing Antibody Market, by End-User, 2023-2030 (US$ Mn)
TABLE 147 Spain Neutralizing Antibody Market, by Disease Target, 2017-2022 (US$ Mn)
TABLE 148 Spain Neutralizing Antibody Market, by Disease Target, 2023-2030 (US$ Mn)
TABLE 149 Spain Neutralizing Antibody Market, by Technology and Production Process, 2017-2022 (US$ Mn)
TABLE 150 Spain Neutralizing Antibody Market, by Technology and Production Process, 2023-2030 (US$ Mn)
TABLE 151 Benelux Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2017-2022 (US$ Mn)
TABLE 152 Benelux Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2023-2030 (US$ Mn)
TABLE 153 Benelux Neutralizing Antibody Market, by Application, 2017-2022 (US$ Mn)
TABLE 154 Benelux Neutralizing Antibody Market, by Application, 2023-2030 (US$ Mn)
TABLE 155 Benelux Neutralizing Antibody Market, by End-User, 2017-2022 (US$ Mn)
TABLE 156 Benelux Neutralizing Antibody Market, by End-User, 2023-2030 (US$ Mn)
TABLE 157 Benelux Neutralizing Antibody Market, by Disease Target, 2017-2022 (US$ Mn)
TABLE 158 Benelux Neutralizing Antibody Market, by Disease Target, 2023-2030 (US$ Mn)
TABLE 159 Benelux Neutralizing Antibody Market, by Technology and Production Process, 2017-2022 (US$ Mn)
TABLE 160 Benelux Neutralizing Antibody Market, by Technology and Production Process, 2023-2030 (US$ Mn)
TABLE 161 Russia Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2017-2022 (US$ Mn)
TABLE 162 Russia Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2023-2030 (US$ Mn)
TABLE 163 Russia Neutralizing Antibody Market, by Application, 2017-2022 (US$ Mn)
TABLE 164 Russia Neutralizing Antibody Market, by Application, 2023-2030 (US$ Mn)
TABLE 165 Russia Neutralizing Antibody Market, by End-User, 2017-2022 (US$ Mn)
TABLE 166 Russia Neutralizing Antibody Market, by End-User, 2023-2030 (US$ Mn)
TABLE 167 Russia Neutralizing Antibody Market, by Disease Target, 2017-2022 (US$ Mn)
TABLE 168 Russia Neutralizing Antibody Market, by Disease Target, 2023-2030 (US$ Mn)
TABLE 169 Russia Neutralizing Antibody Market, by Technology and Production Process, 2017-2022 (US$ Mn)
TABLE 170 Russia Neutralizing Antibody Market, by Technology and Production Process, 2023-2030 (US$ Mn)
TABLE 171 Rest of Europe Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2017-2022 (US$ Mn)
TABLE 172 Rest of Europe Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2023-2030 (US$ Mn)
TABLE 173 Rest of Europe Neutralizing Antibody Market, by Application, 2017-2022 (US$ Mn)
TABLE 174 Rest of Europe Neutralizing Antibody Market, by Application, 2023-2030 (US$ Mn)
TABLE 175 Rest of Europe Neutralizing Antibody Market, by End-User, 2017-2022 (US$ Mn)
TABLE 176 Rest of Europe Neutralizing Antibody Market, by End-User, 2023-2030 (US$ Mn)
TABLE 177 Rest of Europe Neutralizing Antibody Market, by Disease Target, 2017-2022 (US$ Mn)
TABLE 178 Rest of Europe Neutralizing Antibody Market, by Disease Target, 2023-2030 (US$ Mn)
TABLE 179 Rest of Europe Neutralizing Antibody Market, by Technology and Production Process, 2017-2022 (US$ Mn)
TABLE 180 Rest of Europe Neutralizing Antibody Market, by Technology and Production Process, 2023-2030 (US$ Mn)
TABLE 181 Asia Pacific Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2017-2022 (US$ Mn)
TABLE 182 Asia Pacific Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2023-2030 (US$ Mn)
TABLE 183 Asia Pacific Neutralizing Antibody Market, by Application, 2017-2022 (US$ Mn)
TABLE 184 Asia Pacific Neutralizing Antibody Market, by Application, 2023-2030 (US$ Mn)
TABLE 185 Asia Pacific Neutralizing Antibody Market, by End-User, 2017-2022 (US$ Mn)
TABLE 186 Asia Pacific Neutralizing Antibody Market, by End-User, 2023-2030 (US$ Mn)
TABLE 187 Asia Pacific Neutralizing Antibody Market, by Disease Target, 2017-2022 (US$ Mn)
TABLE 188 Asia Pacific Neutralizing Antibody Market, by Disease Target, 2023-2030 (US$ Mn)
TABLE 189 Asia Pacific Neutralizing Antibody Market, by Technology and Production Process, 2017-2022 (US$ Mn)
TABLE 190 Asia Pacific Neutralizing Antibody Market, by Technology and Production Process, 2023-2030 (US$ Mn)
TABLE 191 China Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2017-2022 (US$ Mn)
TABLE 192 China Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2023-2030 (US$ Mn)
TABLE 193 China Neutralizing Antibody Market, by Application, 2017-2022 (US$ Mn)
TABLE 194 China Neutralizing Antibody Market, by Application, 2023-2030 (US$ Mn)
TABLE 195 China Neutralizing Antibody Market, by End-User, 2017-2022 (US$ Mn)
TABLE 196 China Neutralizing Antibody Market, by End-User, 2023-2030 (US$ Mn)
TABLE 197 China Neutralizing Antibody Market, by Disease Target, 2017-2022 (US$ Mn)
TABLE 198 China Neutralizing Antibody Market, by Disease Target, 2023-2030 (US$ Mn)
TABLE 199 China Neutralizing Antibody Market, by Technology and Production Process, 2017-2022 (US$ Mn)
TABLE 200 China Neutralizing Antibody Market, by Technology and Production Process, 2023-2030 (US$ Mn)
TABLE 201 Japan Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2017-2022 (US$ Mn)
TABLE 202 Japan Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2023-2030 (US$ Mn)
TABLE 203 Japan Neutralizing Antibody Market, by Application, 2017-2022 (US$ Mn)
TABLE 204 Japan Neutralizing Antibody Market, by Application, 2023-2030 (US$ Mn)
TABLE 205 Japan Neutralizing Antibody Market, by End-User, 2017-2022 (US$ Mn)
TABLE 206 Japan Neutralizing Antibody Market, by End-User, 2023-2030 (US$ Mn)
TABLE 207 Japan Neutralizing Antibody Market, by Disease Target, 2017-2022 (US$ Mn)
TABLE 208 Japan Neutralizing Antibody Market, by Disease Target, 2023-2030 (US$ Mn)
TABLE 209 Japan Neutralizing Antibody Market, by Technology and Production Process, 2017-2022 (US$ Mn)
TABLE 210 Japan Neutralizing Antibody Market, by Technology and Production Process, 2023-2030 (US$ Mn)
TABLE 211 India Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2017-2022 (US$ Mn)
TABLE 212 India Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2023-2030 (US$ Mn)
TABLE 213 India Neutralizing Antibody Market, by Application, 2017-2022 (US$ Mn)
TABLE 214 India Neutralizing Antibody Market, by Application, 2023-2030 (US$ Mn)
TABLE 215 India Neutralizing Antibody Market, by End-User, 2017-2022 (US$ Mn)
TABLE 216 India Neutralizing Antibody Market, by End-User, 2023-2030 (US$ Mn)
TABLE 217 India Neutralizing Antibody Market, by Disease Target, 2017-2022 (US$ Mn)
TABLE 218 India Neutralizing Antibody Market, by Disease Target, 2023-2030 (US$ Mn)
TABLE 219 India Neutralizing Antibody Market, by Technology and Production Process, 2017-2022 (US$ Mn)
TABLE 220 India Neutralizing Antibody Market, by Technology and Production Process, 2023-2030 (US$ Mn)
TABLE 221 South Korea Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2017-2022 (US$ Mn)
TABLE 222 South Korea Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2023-2030 (US$ Mn)
TABLE 223 South Korea Neutralizing Antibody Market, by Application, 2017-2022 (US$ Mn)
TABLE 224 South Korea Neutralizing Antibody Market, by Application, 2023-2030 (US$ Mn)
TABLE 225 South Korea Neutralizing Antibody Market, by End-User, 2017-2022 (US$ Mn)
TABLE 226 South Korea Neutralizing Antibody Market, by End-User, 2023-2030 (US$ Mn)
TABLE 227 South Korea Neutralizing Antibody Market, by Disease Target, 2017-2022 (US$ Mn)
TABLE 228 South Korea Neutralizing Antibody Market, by Disease Target, 2023-2030 (US$ Mn)
TABLE 229 South Korea Neutralizing Antibody Market, by Technology and Production Process, 2017-2022 (US$ Mn)
TABLE 230 South Korea Neutralizing Antibody Market, by Technology and Production Process, 2023-2030 (US$ Mn)
TABLE 231 South-East Asia Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2017-2022 (US$ Mn)
TABLE 232 South-East Asia Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2023-2030 (US$ Mn)
TABLE 233 South-East Asia Neutralizing Antibody Market, by Application, 2017-2022 (US$ Mn)
TABLE 234 South-East Asia Neutralizing Antibody Market, by Application, 2023-2030 (US$ Mn)
TABLE 235 South-East Asia Neutralizing Antibody Market, by End-User, 2017-2022 (US$ Mn)
TABLE 236 South-East Asia Neutralizing Antibody Market, by End-User, 2023-2030 (US$ Mn)
TABLE 237 South-East Asia Neutralizing Antibody Market, by Disease Target, 2017-2022 (US$ Mn)
TABLE 238 South-East Asia Neutralizing Antibody Market, by Disease Target, 2023-2030 (US$ Mn)
TABLE 239 South-East Asia Neutralizing Antibody Market, by Technology and Production Process, 2017-2022 (US$ Mn)
TABLE 240 South-East Asia Neutralizing Antibody Market, by Technology and Production Process, 2023-2030 (US$ Mn)
TABLE 241 Rest of Asia Pacific Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2017-2022 (US$ Mn)
TABLE 242 Rest of Asia Pacific Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2023-2030 (US$ Mn)
TABLE 243 Rest of Asia Pacific Neutralizing Antibody Market, by Application, 2017-2022 (US$ Mn)
TABLE 244 Rest of Asia Pacific Neutralizing Antibody Market, by Application, 2023-2030 (US$ Mn)
TABLE 245 Rest of Asia Pacific Neutralizing Antibody Market, by End-User, 2017-2022 (US$ Mn)
TABLE 246 Rest of Asia Pacific Neutralizing Antibody Market, by End-User, 2023-2030 (US$ Mn)
TABLE 247 Rest of Asia Pacific Neutralizing Antibody Market, by Disease Target, 2017-2022 (US$ Mn)
TABLE 248 Rest of Asia Pacific Neutralizing Antibody Market, by Disease Target, 2023-2030 (US$ Mn)
TABLE 249 Rest of Asia Pacific Neutralizing Antibody Market, by Technology and Production Process, 2017-2022 (US$ Mn)
TABLE 250 Rest of Asia Pacific Neutralizing Antibody Market, by Technology and Production Process, 2023-2030 (US$ Mn)
TABLE 251 Latin America Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2017-2022 (US$ Mn)
TABLE 252 Latin America Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2023-2030 (US$ Mn)
TABLE 253 Latin America Neutralizing Antibody Market, by Application, 2017-2022 (US$ Mn)
TABLE 254 Latin America Neutralizing Antibody Market, by Application, 2023-2030 (US$ Mn)
TABLE 255 Latin America Neutralizing Antibody Market, by End-User, 2017-2022 (US$ Mn)
TABLE 256 Latin America Neutralizing Antibody Market, by End-User, 2023-2030 (US$ Mn)
TABLE 257 Latin America Neutralizing Antibody Market, by Disease Target, 2017-2022 (US$ Mn)
TABLE 258 Latin America Neutralizing Antibody Market, by Disease Target, 2023-2030 (US$ Mn)
TABLE 259 Latin America Neutralizing Antibody Market, by Technology and Production Process, 2017-2022 (US$ Mn)
TABLE 260 Latin America Neutralizing Antibody Market, by Technology and Production Process, 2023-2030 (US$ Mn)
TABLE 261 Brazil Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2017-2022 (US$ Mn)
TABLE 262 Brazil Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2023-2030 (US$ Mn)
TABLE 263 Brazil Neutralizing Antibody Market, by Application, 2017-2022 (US$ Mn)
TABLE 264 Brazil Neutralizing Antibody Market, by Application, 2023-2030 (US$ Mn)
TABLE 265 Brazil Neutralizing Antibody Market, by End-User, 2017-2022 (US$ Mn)
TABLE 266 Brazil Neutralizing Antibody Market, by End-User, 2023-2030 (US$ Mn)
TABLE 267 Brazil Neutralizing Antibody Market, by Disease Target, 2017-2022 (US$ Mn)
TABLE 268 Brazil Neutralizing Antibody Market, by Disease Target, 2023-2030 (US$ Mn)
TABLE 269 Brazil Neutralizing Antibody Market, by Technology and Production Process, 2017-2022 (US$ Mn)
TABLE 270 Brazil Neutralizing Antibody Market, by Technology and Production Process, 2023-2030 (US$ Mn)
TABLE 271 Argentina Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2017-2022 (US$ Mn)
TABLE 272 Argentina Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2023-2030 (US$ Mn)
TABLE 273 Argentina Neutralizing Antibody Market, by Application, 2017-2022 (US$ Mn)
TABLE 274 Argentina Neutralizing Antibody Market, by Application, 2023-2030 (US$ Mn)
TABLE 275 Argentina Neutralizing Antibody Market, by End-User, 2017-2022 (US$ Mn)
TABLE 276 Argentina Neutralizing Antibody Market, by End-User, 2023-2030 (US$ Mn)
TABLE 277 Argentina Neutralizing Antibody Market, by Disease Target, 2017-2022 (US$ Mn)
TABLE 278 Argentina Neutralizing Antibody Market, by Disease Target, 2023-2030 (US$ Mn)
TABLE 279 Argentina Neutralizing Antibody Market, by Technology and Production Process, 2017-2022 (US$ Mn)
TABLE 280 Argentina Neutralizing Antibody Market, by Technology and Production Process, 2023-2030 (US$ Mn)
TABLE 281 Rest of Latin America Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2017-2022 (US$ Mn)
TABLE 282 Rest of Latin America Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2023-2030 (US$ Mn)
TABLE 283 Rest of Latin America Neutralizing Antibody Market, by Application, 2017-2022 (US$ Mn)
TABLE 284 Rest of Latin America Neutralizing Antibody Market, by Application, 2023-2030 (US$ Mn)
TABLE 285 Rest of Latin America Neutralizing Antibody Market, by End-User, 2017-2022 (US$ Mn)
TABLE 286 Rest of Latin America Neutralizing Antibody Market, by End-User, 2023-2030 (US$ Mn)
TABLE 287 Rest of Latin America Neutralizing Antibody Market, by Disease Target, 2017-2022 (US$ Mn)
TABLE 288 Rest of Latin America Neutralizing Antibody Market, by Disease Target, 2023-2030 (US$ Mn)
TABLE 289 Rest of Latin America Neutralizing Antibody Market, by Technology and Production Process, 2017-2022 (US$ Mn)
TABLE 290 Rest of Latin America Neutralizing Antibody Market, by Technology and Production Process, 2023-2030 (US$ Mn)
TABLE 291 Middle East Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2017-2022 (US$ Mn)
TABLE 292 Middle East Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2023-2030 (US$ Mn)
TABLE 293 Middle East Neutralizing Antibody Market, by Application, 2017-2022 (US$ Mn)
TABLE 294 Middle East Neutralizing Antibody Market, by Application, 2023-2030 (US$ Mn)
TABLE 295 Middle East Neutralizing Antibody Market, by End-User, 2017-2022 (US$ Mn)
TABLE 296 Middle East Neutralizing Antibody Market, by End-User, 2023-2030 (US$ Mn)
TABLE 297 Middle East Neutralizing Antibody Market, by Disease Target, 2017-2022 (US$ Mn)
TABLE 298 Middle East Neutralizing Antibody Market, by Disease Target, 2023-2030 (US$ Mn)
TABLE 299 Middle East Neutralizing Antibody Market, by Technology and Production Process, 2017-2022 (US$ Mn)
TABLE 300 Middle East Neutralizing Antibody Market, by Technology and Production Process, 2023-2030 (US$ Mn)
TABLE 301 UAE Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2017-2022 (US$ Mn)
TABLE 302 UAE Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2023-2030 (US$ Mn)
TABLE 303 UAE Neutralizing Antibody Market, by Application, 2017-2022 (US$ Mn)
TABLE 304 UAE Neutralizing Antibody Market, by Application, 2023-2030 (US$ Mn)
TABLE 305 UAE Neutralizing Antibody Market, by End-User, 2017-2022 (US$ Mn)
TABLE 306 UAE Neutralizing Antibody Market, by End-User, 2023-2030 (US$ Mn)
TABLE 307 UAE Neutralizing Antibody Market, by Disease Target, 2017-2022 (US$ Mn)
TABLE 308 UAE Neutralizing Antibody Market, by Disease Target, 2023-2030 (US$ Mn)
TABLE 309 UAE Neutralizing Antibody Market, by Technology and Production Process, 2017-2022 (US$ Mn)
TABLE 310 UAE Neutralizing Antibody Market, by Technology and Production Process, 2023-2030 (US$ Mn)
TABLE 311 Saudi Arabia Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2017-2022 (US$ Mn)
TABLE 312 Saudi Arabia Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2023-2030 (US$ Mn)
TABLE 313 Saudi Arabia Neutralizing Antibody Market, by Application, 2017-2022 (US$ Mn)
TABLE 314 Saudi Arabia Neutralizing Antibody Market, by Application, 2023-2030 (US$ Mn)
TABLE 315 Saudi Arabia Neutralizing Antibody Market, by End-User, 2017-2022 (US$ Mn)
TABLE 316 Saudi Arabia Neutralizing Antibody Market, by End-User, 2023-2030 (US$ Mn)
TABLE 317 Saudi Arabia Neutralizing Antibody Market, by Disease Target, 2017-2022 (US$ Mn)
TABLE 318 Saudi Arabia Neutralizing Antibody Market, by Disease Target, 2023-2030 (US$ Mn)
TABLE 319 Saudi Arabia Neutralizing Antibody Market, by Technology and Production Process, 2017-2022 (US$ Mn)
TABLE 320 Saudi Arabia Neutralizing Antibody Market, by Technology and Production Process, 2023-2030 (US$ Mn)
TABLE 321 Rest of Middle East Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2017-2022 (US$ Mn)
TABLE 322 Rest of Middle East Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2023-2030 (US$ Mn)
TABLE 323 Rest of Middle East Neutralizing Antibody Market, by Application, 2017-2022 (US$ Mn)
TABLE 324 Rest of Middle East Neutralizing Antibody Market, by Application, 2023-2030 (US$ Mn)
TABLE 325 Rest of Middle East Neutralizing Antibody Market, by End-User, 2017-2022 (US$ Mn)
TABLE 326 Rest of Middle East Neutralizing Antibody Market, by End-User, 2023-2030 (US$ Mn)
TABLE 327 Rest of Middle East Neutralizing Antibody Market, by Disease Target, 2017-2022 (US$ Mn)
TABLE 328 Rest of Middle East Neutralizing Antibody Market, by Disease Target, 2023-2030 (US$ Mn)
TABLE 329 Rest of Middle East Neutralizing Antibody Market, by Technology and Production Process, 2017-2022 (US$ Mn)
TABLE 330 Rest of Middle East Neutralizing Antibody Market, by Technology and Production Process, 2023-2030 (US$ Mn)
TABLE 331 Africa Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2017-2022 (US$ Mn)
TABLE 332 Africa Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2023-2030 (US$ Mn)
TABLE 333 Africa Neutralizing Antibody Market, by Application, 2017-2022 (US$ Mn)
TABLE 334 Africa Neutralizing Antibody Market, by Application, 2023-2030 (US$ Mn)
TABLE 335 Africa Neutralizing Antibody Market, by End-User, 2017-2022 (US$ Mn)
TABLE 336 Africa Neutralizing Antibody Market, by End-User, 2023-2030 (US$ Mn)
TABLE 337 Africa Neutralizing Antibody Market, by Disease Target, 2017-2022 (US$ Mn)
TABLE 338 Africa Neutralizing Antibody Market, by Disease Target, 2023-2030 (US$ Mn)
TABLE 339 Africa Neutralizing Antibody Market, by Technology and Production Process, 2017-2022 (US$ Mn)
TABLE 340 Africa Neutralizing Antibody Market, by Technology and Production Process, 2023-2030 (US$ Mn)
TABLE 341 South Africa Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2017-2022 (US$ Mn)
TABLE 342 South Africa Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2023-2030 (US$ Mn)
TABLE 343 South Africa Neutralizing Antibody Market, by Application, 2017-2022 (US$ Mn)
TABLE 344 South Africa Neutralizing Antibody Market, by Application, 2023-2030 (US$ Mn)
TABLE 345 South Africa Neutralizing Antibody Market, by End-User, 2017-2022 (US$ Mn)
TABLE 346 South Africa Neutralizing Antibody Market, by End-User, 2023-2030 (US$ Mn)
TABLE 347 South Africa Neutralizing Antibody Market, by Disease Target, 2017-2022 (US$ Mn)
TABLE 348 South Africa Neutralizing Antibody Market, by Disease Target, 2023-2030 (US$ Mn)
TABLE 349 South Africa Neutralizing Antibody Market, by Technology and Production Process, 2017-2022 (US$ Mn)
TABLE 350 South Africa Neutralizing Antibody Market, by Technology and Production Process, 2023-2030 (US$ Mn)
TABLE 351 Egypt Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2017-2022 (US$ Mn)
TABLE 352 Egypt Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2023-2030 (US$ Mn)
TABLE 353 Egypt Neutralizing Antibody Market, by Application, 2017-2022 (US$ Mn)
TABLE 354 Egypt Neutralizing Antibody Market, by Application, 2023-2030 (US$ Mn)
TABLE 355 Egypt Neutralizing Antibody Market, by End-User, 2017-2022 (US$ Mn)
TABLE 356 Egypt Neutralizing Antibody Market, by End-User, 2023-2030 (US$ Mn)
TABLE 357 Egypt Neutralizing Antibody Market, by Disease Target, 2017-2022 (US$ Mn)
TABLE 358 Egypt Neutralizing Antibody Market, by Disease Target, 2023-2030 (US$ Mn)
TABLE 359 Egypt Neutralizing Antibody Market, by Technology and Production Process, 2017-2022 (US$ Mn)
TABLE 360 Egypt Neutralizing Antibody Market, by Technology and Production Process, 2023-2030 (US$ Mn)
TABLE 361 Rest of Africa Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2017-2022 (US$ Mn)
TABLE 362 Rest of Africa Neutralizing Antibody Market, by Type of Neutralizing Antibody, 2023-2030 (US$ Mn)
TABLE 363 Rest of Africa Neutralizing Antibody Market, by Application, 2017-2022 (US$ Mn)
TABLE 364 Rest of Africa Neutralizing Antibody Market, by Application, 2023-2030 (US$ Mn)
TABLE 365 Rest of Africa Neutralizing Antibody Market, by End-User, 2017-2022 (US$ Mn)
TABLE 366 Rest of Africa Neutralizing Antibody Market, by End-User, 2023-2030 (US$ Mn)
TABLE 367 Rest of Africa Neutralizing Antibody Market, by Disease Target, 2017-2022 (US$ Mn)
TABLE 368 Rest of Africa Neutralizing Antibody Market, by Disease Target, 2023-2030 (US$ Mn)
TABLE 369 Rest of Africa Neutralizing Antibody Market, by Technology and Production Process, 2017-2022 (US$ Mn)
TABLE 370 Rest of Africa Neutralizing Antibody Market, by Technology and Production Process, 2023-2030 (US$ Mn)

How big is the global market for neutralizing antibody right now?

In 2022, the market for neutralizing antibody was estimated to be worth USD 191254.5 million.

What is the neutralizing antibody market’s anticipated growth rate from 2023 to 2030?

The market for neutralizing antibody is anticipated to increase at a CAGR of 8.90% from 2023 to 2030, reaching USD 378298.57 million in 2030.

Regarding the type of neutralizing antibody, which market category is leading?

In the category of neutralizing antibodies, monoclonal antibodies (mAbs) are the most often used type.

Which segment is leading the market in terms of application?

Cancer, by application, is the notable segment.

Which end-user segment is estimated to have the highest CAGR throughout the forecast period?

The hospital and clinic category is anticipated to exhibit the highest CAGR during the projection period.

Purchase Options

Single User

$3699

Multi User

$4699

Custom Report

$6699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –